Search

for
Search:

Research

5 / 1000+ results

Challenges of Securing Insurance Approval for Oral Tofacitinib Treatment of Alopecia Areata: A Multi-Institutional Retrospective Review

research 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review

June 2020 in “Journal of Investigative Dermatology”

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

research The therapeutic, diagnostic, and prognostic values of extracellular vesicles (exosomes) in dermatology: A systematic review

9 citations , July 2024 in “JAAD reviews.”

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

research The only way is ethics? Applying for National Health Service ethical approval and governance for research with children

3 citations , March 2019 in “Children's Geographies”

Getting ethical approval for research with children is important but can be complex and time-consuming, sometimes leading to the exclusion of certain age groups.

Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims

research Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims

23 citations , July 2021 in “Advances in Therapy”

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

research Japan Strengthens Regenerative Medicine Oversight

19 citations , February 2018 in “Cell Stem Cell”

Japan improved its regulation of regenerative medicine to ensure safety and prevent unproven treatments.

View more "insurance approval" in research →

Community Join

5 / 733 results

community When will Breezula, SM04554, Follica FOL-004, follicum FOL-005 arrive in Canada?

in Question 7 upvotes 6 years ago

The conversation is about the availability of hair loss treatments Breezula, SM04554, Follica FOL-004, and Follicum FOL-005 in Canada after FDA approval, including potential delays, loopholes for obtaining them, and insurance coverage.

community Clascoterone (Winlevi) Update for Canada

in Treatment 15 upvotes 3 years ago

Clascoterone cream was submitted for review to Health Canada in August 2022, with hopes of approval within 3-6 months. It may potentially enhance finasteride's effects for hair loss treatment.

community Clascoterone (Winlevi) now approved in Canada

in Product 14 upvotes 3 years ago

The conversation is about the approval of Clascoterone (Winlevi) in Canada for hair loss treatment. One user expressed skepticism about its effectiveness due to low concentration.

community Why is dutasteride approved for hair loss in Japan and South Korea but not for USA?

in Research/Science 34 upvotes 4 years ago

The reasoning for GSK's approval of dutasteride for hair loss in Japan and South Korea but not the US, with alternatives such as finasteride, minoxidil and RU58841 mentioned.

community Why do most people on Reddit prefer finasteride over dutasteride?

in Treatment 101 upvotes 1 year ago

Finasteride is favored for hair loss due to FDA approval, accessibility, and manageable side effects. Dutasteride, though more effective in reducing DHT, is used off-label and may have more side effects.

View more "insurance approval" in community →

Learn

3 / 801 results

learn Bimatoprost

a synthetic prostamide used to treat eyelashes also shows promise for stimulating hair growth on scalp

learn Osteopontin

signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

learn Overview

View more "insurance approval" in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →